Metabolic Reprogramming of NSUN2 -Mediated m 5 C Modification Promotes the Progression of Hepatocellular Carcinoma by Restricting Natural Killer Cell-Mediated Cytotoxicity
Cancer Communications · 2026
DOI: 10.34133/cancomm.0043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Communications, 2026. Verfasst von Shengwei Mao und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, P. R. China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Killer Cells, Natural, Liver Neoplasms, Methyltransferases. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Young Scientists Fund of the National Natural Science Foundation of China, Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
Background
Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality, with resistance to immunotherapy posing a major clinical challenge. Natural killer (NK) cells exhibit impaired infiltration and cytotoxicity in HCC; however, the mechanisms underlying NK cell-mediated immune evasion are still poorly understood. This study investigated how NOP2/Sun RNA methyltransferase 2 (NSUN2), a 5-methylcytosine (m 5 C) RNA methyltransferase, induces metabolic reprogramming and immunosuppression to drive HCC progression.
Methods
We conducted a genome-wide CRISPR screen in HCC cells cocultured with NK cells. To delineate the downstream mechanisms, we integrated profiling of the m5C epitranscriptome, transcriptome, and chromatin landscape with metabolic characterization. The impact of NSUN2 on histone lactylation and programmed cell death 1 ligand 1 (PD-L1) transcription was further investigated. Functional assays in vitro and in vivo using syngeneic murine models and pharmacological inhibition validated these findings. Clinical relevance was assessed using patient tissues, The Cancer Genome Atlas dataset, and immunotherapy cohorts.
Results
Genome-wide CRISPR screening in HCC cell–NK cell coculture models identified NSUN2 as a key suppressor of NK cell-mediated cytotoxicity. Mechanistically, NSUN2-mediated RNA m 5 C modification enhanced the messenger RNA stability and expression of glycolytic enzymes, including enolase 1 ( ENO1 ), pyruvate kinase M1/2 ( PKM ), and lactate dehydrogenase A ( LDHA ), thereby increasing lactate production. Accumulated lactate promoted histone H3 lysine 18 lactylation (H3K18la), which enhanced chromatin accessibility at the CD274 (encoding PD-L1) promoter and recruited signal transducer and activator of transcription 3 (STAT3) to drive PD-L1 expression, ultimately inhibiting NK cell-mediated cytotoxicity. Clinically, high NSUN2 expression was associated with elevated PD-L1 levels, poor prognosis, and immunotherapy resistance in patients with HCC. In vivo, NSUN2 knockout increased NK cell infiltration and suppressed tumor growth, while the STAT3 inhibitor TTI-101 combined with anti-PD-L1 therapy enhanced NK cell cytotoxicity and inhibited HCC progression.
Conclusions
Our data demonstrated that NSUN2 drove immune evasion in HCC by coupling m 5 C-dependent glycolytic reprogramming with H3K18la-mediated epigenetic activation of PD-L1. These findings suggest that NSUN2 could represent a critical nexus between m 5 C RNA methylation and immunosuppression, providing a therapeutic rationale for combination immunotherapy in HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, P. R. China.
- Research Unit of Liver Cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences, Beijing, P. R. China.
- Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, P. R. China.
- Department of General Surgery (Thyroid and Breast), Zhongshan Hospital, Fudan University, Shanghai, P. R. China.
- Department of General Surgery, Shanghai Geriatric Medical Center (Zhongshan Hospital Minhang Campus), Fudan University, Shanghai, P. R. China.
- College of Clinical Medicine, Shanghai Medical College, Fudan University, Shanghai, P. R. China.
ORCID-Profile: Shengwei Mao, Xiangyu Zhang, Weiren Liu
Förderung
- National Natural Science Foundation of China
- Young Scientists Fund of the National Natural Science Foundation of China
- Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences
- Clinical Research Plan of Shanghai Hospital Development Center
- Shanghai Municipal Health Commission
- Shanghai Sailing Program
Zitieren
APA
Mao, S., Fang, Y., Gao, J., Chen, J., Guan, Z., Zhao, X., Wu, J., Wu, X., Zhu, G., Zhang, X., Zhao, Q., Yang, R., Wang, Y., Chu, T., Bu, Y., Fu, J., Li, H., Tang, Z., Shi, Y., …, & Liu, W. (2026). Metabolic Reprogramming of NSUN2 -Mediated m 5 C Modification Promotes the Progression of Hepatocellular Carcinoma by Restricting Natural Killer Cell-Mediated Cytotoxicity. Cancer Communications. https://doi.org/10.34133/cancomm.0043
Vancouver
Mao S, Fang Y, Gao J, Chen J, Guan Z, Zhao X, et al. Metabolic Reprogramming of NSUN2 -Mediated m 5 C Modification Promotes the Progression of Hepatocellular Carcinoma by Restricting Natural Killer Cell-Mediated Cytotoxicity. Cancer Communications. 2026. doi:10.34133/cancomm.0043
BibTeX
@article{Mao2026,
author = {Mao, Shengwei and Fang, Yuan and Gao, Jun and Chen, Jiafeng and Guan, Zhiqi and Zhao, Xuhui and Wu, Jinglei and Wu, Xiaoling and Zhu, Guiqi and Zhang, Xiangyu and Zhao, Qianfu and Yang, Rui and Wang, Yi and Chu, Tianhao and Bu, Yichao and Fu, Jialu and Li, Hongxu and Tang, Zheng and Shi, Yinghong and Zhou, Jian and Fan, Jia and Jiang, Jinling and Liu, Weiren},
title = {Metabolic Reprogramming of NSUN2 -Mediated m 5 C Modification Promotes the Progression of Hepatocellular Carcinoma by Restricting Natural Killer Cell-Mediated Cytotoxicity},
journal = {Cancer Communications},
year = {2026},
doi = {10.34133/cancomm.0043}
}
EUVIMED